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A B  STRA CT  Multidrug resistance  (MDR)  mediated by overexpression of the MDR protein  (P-glycoprotein) has 
been associated with intracellular alkalinization, membrane depolarization, and other cellular alterations. How- 
ever, virtually all MDR cell lines studied in detail have been created via protocols that involve growth on chemo- 
therapeutic drugs, which can alter cells in many ways. Thus it is not clear which phenotypic alterations are explic- 
itly due  to MDR protein overexpression alone. To more precisely define  the MDR phenotype mediated by hu 
MDR 1 protein, we co-transfected hu MDR 1 cDNA and a neomycin resistance marker into LR73 Chinese hamster 
ovary fibroblasts and selected stable G418  (geneticin)  resistant transfectants. Several clones expressing different 
levels of hu MDR 1 protein were isolated. Unlike previous work with hu MDR 1 transfectants, the clones were not 
further selected with, or maintained on, chemotherapeutic drugs.  These clones were analyzed for chemothera- 
peutic drug resistance, intracellular pH (pHi), membrane electrical potential (Vm), and stability ofMDR 1 protein 
overexpression. LR73/hu MDR 1 clones exhibit elevated pH  i and are depolarized, consistent with previous work 
with  LR73/mu  MDR  1 transfectants  (Luz, J.G.L.Y. Wei,  S.  Basu,  and P.D.  Roepe.  1994.  Biochemistry. 33:7239- 
7249). The extent of these perturbations is related to the level of hu MDR 1 protein that is expressed. Cytotoxicity 
experiments with untransfected LR73 cells with elevated pHi due to manipulating percent CO  2 show that the pHi 
perturbations in the MDR 1 clones can account for much of the measured drug resistance. Membrane depolariza- 
tion in the absence of MDR protein expression is also found to confer mild drug resistance, and we find that the 
pH~ and V,1  changes  can  conceivably account for the  altered  drug accumulation  measured  for representative 
clones. These data indicate that the MDR phenotype unequivocally mediated by MDR 1 protein overexpression 
alone can be fully explained by the perturbations in V  m and pH  i that accompany this overexpression. In addition, 
MDR mediated by MDR protein overexpression alone differs significantly from that observed for MDR cell lines 
expressing similar levels of MDR protein but also exposed to chemotherapeutic drugs. 
KEY  WORDS:  P-glycoprotein ￿9 multidrug resistance ￿9 intracellular pH * altered partitioning 
INTRODUCTION 
Elucidation  of the molecular mechanism of multidrug 
resistance  (MDR) l  protein-mediated  multidrug  resis- 
tance  is a  key goal of cancer pharmacology as well as 
membrane  transport  physiology.  Recent  analysis  of 
MDR  protein  function  (Bornmann  and  Roepe,  1994; 
Luckie  et al.,  1994;  Luz et  al.,  1994;  Reutz  and  Gros, 
1994;  Hardy et al.,  1995;  Shapiro and Ling,  1995)  and 
other data (Wadkins and Houghton, 1993; Mayer et al., 
1985a,  b; Mayer et al.,  1986; Praet et al.,  1993; Wadkins 
and  Houghton,  1995;  Wei  et  al.,  1995;  Wadkins  and 
Roepe,  1996)  suggest that  the  mechanism for altered 
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drug  retention  and  resistance  in  MDR  cells  is  more 
complex  than  initially  thought  (Dane*,  1973).  First,  a 
distinction  should  be  made  between  phenotypic  fea- 
tures  that  are  unequivocally  mediated  by overexpres- 
sion of MDR protein  and those  that may be mediated 
by other  events due  to exposing cells to  chemothera- 
peutic  drugs  (Roepe,  1995).  With  a  few  exceptions 
(Guild et al., 1988; Devauh and Gros, 1990; Valverde et 
al.,  1992;  Luz  et  al.,  1994)  analysis  of MDR  protein 
function  has  been  done  with  cells  selected  or  main- 
tained  on  potent  chemotherapeutic  drug(s).  These 
drugs have a variety of complex effects, thus the precise 
description of the MDR protein-mediated MDR pheno- 
type remains vague. This greatly clouds discussions  of 
MDR protein function. For example, most model MDR 
cell lines exhibit -> 10Z-fold levels of drug resistance, but 
MDR protein overexpression per se has not yet been as- 
sociated  with  particularly  high  (>10-fold)  levels  of 
drug  resistance  (Guild et al.,  1988;  Devault and  Gros, 
1990).  Thus,  most studies  (including  analysis of MDR 
protein mutants)  have likely examined behavior that is 
at least in part due to drug exposure rather than MDR 
protein  overexpression. It is critical that MDR protein 
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been exposed to chemotherapeutic drugs before analysis. 
A vigorously championed model for MDR protein is 
that it acts as a drug pump, coupling hydrolysis of ade- 
nosine  5'-triphosphate  (ATP)  to  direct  movement of 
drug  out  of  a  cell  against  a  concentration  gradient 
(Gottesman and Pastan,  1993; Sharom et al.,  1993; Ru- 
etz and Gros, 1994; Shapiro and Ling, 1995). However, 
verification  of predicted  thermodynamic  and  kinetic 
features of putative drug pumping has been difficult to 
obtain (Roepe, 1992; Bornmann and Roepe, 1994; Sha- 
piro and Ling, 1995; Roepe et al., 1996). This has led to 
(a)  more involved models such as the "flippase" (Hig- 
gins and Gottesman,  1992)  or "vacuum cleaner"  (Got- 
tesman and Pastan,  1993)  models, which attempt to ac- 
count for the observed unusual thermodynamic and ki- 
netic  features  or  (b)  alternative  "indirect"  models for 
how overexpression of MDR protein could promote re- 
sistance  to  hundreds  of  structurally  divergent  com- 
pounds without  invoking direct active  transport  (e.g., 
the  "altered  partitioning  model,"  see  Roepe,  1995; 
Wadkins and Roepe,  1996). A third model is the "dual 
function" model (Gill et al., 1992)  in which the protein 
alternates  between  C1-  channel  or  channel  regulator 
and  drug  pump  conformations;  a  fourth  is  the  ATP 
channel  hypothesis  (Abraham  et al.,  1993).  The ATP 
channel model implies that drug resistance may be due 
to changes in pHi and/or Vm triggered by increased ex- 
tracellular ATP (Huang et al., 1992; E1-Moatassim et al., 
1992),  presumably via  a  purinergic  receptor  pathway 
(Al-Awqati, 1995). 
Since  MDR cells exhibit decreased accumulation  of 
many dozens of structurally divergent compounds, any 
permutation of a pump model envisions that MDR pro- 
tein is an extraordinary enzyme that violates the law of 
enzyme specificity. Also, recent studies  (Sharom et al., 
1993; Reutz and Gros, 1994;  Schlemmer and Sirotnak, 
1994)  that  measure  putative  MDR  protein-catalyzed 
drug pumping yield very slow estimated turnover at rea- 
sonable concentrations of drug, 2 as well as very unusual 
and  highly variable ATP hydrolysis:drug  translocation 
stoichiometries. 3 Because of these and other difficulties 
'-'  The vast majority of interpretable drug transport measurements us- 
ing cells, vesicles or proteoliposomes have analyzed transport of 10  ~ 
to 10  6 M levels of drug. At concentrations above several p.M, drugs 
in the "MDR spectrum" form aggregates, and/or exhibit other com- 
plex behavior. 10  ~ to  10 _4 M concentrations  of these drugs and 
other agents believed to be "pumped" by MDR protein can cause sig- 
nificant disruption of lipid structure  (see Wadkins and Houghton, 
1993) that greatly complicates analysis of transport. It is difficult to 
interpret the significance of drug translocation kinetics at concentra- 
tinns greater than several I~M. 
3  The coupling principle states that a defined stoichiometry of energy 
consumption:substrate  translocation  (in  this case, ATP hydrolysis: 
drug translocation) exists for any pump. For ATP-coupled pumps, 
summarized  elsewhere  (Roepe,  1995;  Roepe  et  al., 
1996; Wadkins and Roepe, 1996), it is difficult to visual- 
ize  how  this  measured  translocation  activity  (be  it 
pumping,  "flipping,"  or  "vacuuming")  could  compete 
with passive diffusion  to lower drug accumulation  un- 
der initial  rate conditions  as is typically observed  (see 
Hammond et al., 1989; Stein et al., 1994; Robinson and 
Roepe,  1996),  or how the putative pump couples ATP 
hydrolysis to drug  translocation.  Demant et al.  (1990) 
estimated  the  kinetic  requirements  of a  drug  pump 
necessary to  decrease  accumulation  of drugs  in  MDR 
cells,  and  these  estimates  are  orders  of  magnitude 
higher than the putative drug pumping measured with 
vesicles  (Ruetz and  Gros,  1994;  Schlemmer and  Sirot- 
nak,  1994)  or  proteoliposomes  (Sharom  et  al.,  1993; 
Shapiro and Ling,  1995).  Thus, along with  the lack of 
specificity, significant  kinetic  and  thermodynamic  "di- 
lemma" are revealed when attempting to reconcile the 
pump hypothesis with available data and theory. 
Other data suggest the MDR phenotype is, at least in 
part,  due  to  pHi  and/or  membrane  potential  (Vm) 
changes that accompany MDR protein  overexpression 
(Roepe, 1995). Translocation and retention of chemo- 
therapeutic  drugs  are  influenced  by  small  perturba- 
tions in pH~ or Vm (Mayer et al.,  1985a,  b; Mayer 1986; 
Praet  et  al.,  1993;  Simon  et  al.,  1994;  Wadkins  and 
Roepe,  1996)  and  perturbations  of  similar,  if  not 
greater magnitude typically occur in MDR cells (Roepe, 
1995).  In contrast to these  data,  one study reports no 
change in pHi for a hu MDR 1 transfectant further se- 
lected with  adriamycin  (Altenberg et al.,  1993).  How- 
ever,  this  study did  not  examine V .... and  it has  been 
shown  (Wei  et  al.,  1995)  that  depolarization  is  suffi- 
cient to confer MDR. Also,  the  cells studied  by Alten- 
berg et al. were not analyzed for MDR protein expres- 
sion  by  immunoblot.  This  caveat  is  important,  since 
MDR protein overexpression can be unstable  in  trans- 
fectants (Luz et al.,  1994, and RESULTS) and drug resis- 
tance per se in drug selected cells is no guarantee of a 
MDR protein-mediated  MDR phenotype.  Again,  drug 
selection of model cell lines complicates analysis. 
The  altered  partitioning  model envisions  that these 
pH~ and Vm perturbations  alter diffusion/retention  of 
chemotherapeutic drugs via several overlapping mech- 
anisms  (Roepe,  1995; Wadkins and Roepe,  1996).  It is 
unknown how these perturbations occur, but there are 
several  possibilities.  For  example,  although  there  are 
also conflicting data  (Ehring et al.,  1994),  a variety of 
reports describe anomalous CI- transport in MDR cells 
these stoichiometries are typically between 1:1-1:3. Examination of 
recent drug transport data reveals that extremely high and widely dit: 
ferent ATP hydrolysis:drug translocation stoichiometries can be cal- 
culated in the specific case of MDR protein-mediated  drug transloca- 
tion (see Roepe, 1995; Roepe et al., 1996). 
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consistent with the altered partitioning model, since V~ 
could  be  perturbed  by  changes  in  C1-  permeability, 
Chemotherapeutic  drug selection of cells analyzed for 
Cl-  transport may be responsible for discrepancies in 
the  reported  data.  Another  suggestion  (AI-Awqati, 
1995; Schwiebert et al., 1995)  is that ABC (ATP-binding 
cassette)  transporters  indirectly modulate  ion conduc- 
tances  (which  would  then  influence  V,n  and/or  pHi) 
through  an  autocrine  mechanism  dependent  upon 
ATP  export.  However,  this  model  has  recently  been 
strongly challenged  (Li et al., 1996; Reddy et al., 1996) 
via studies with purified  CFTR protein.  Other  analysis 
(Roepe et al., 1993; Luz et al., 1994)  has revealed para- 
doxical  phenomena  such  as  reduced  AE  (anion  ex- 
change or C1-/HCO3-  exchange)  activity concomitant 
with increased AE expression in MDR cells. If some ver- 
sion of an altered partitioning model is entertained,  it 
is  important  to  deduce  which  pHi/V m alterations  are 
unequivocally due to MDR protein overexpression, and 
also how they occur. 
In devising additional experiments, it is critical to re- 
alize that most model MDR cell lines have been created 
via protocols that include growth on chemotherapeutic 
drugs, which induce many phenomena.  Although MDR 
transfectants  are in theory an  improvement,  almost all 
of these have also been grown  in the presence of che- 
motherapeutic  drug  (Choi  et  al.,  1988;  Lincke  et  al., 
1990;  Gros  et al.,  1991;  Currier  et  al.,  1992;  Loo and 
Clarke,  1993;  Stein  et  al.,  1994;  Beaudet  and  Gros, 
1995).  To  resolve  remaining  questions,  new  experi- 
mental  systems are  required,  and  detailed biophysical 
analysis of these is essential. 
Therefore,  we have  created hu MDR  1  transfectants 
expressing variable levels of MDR  protein without  ex- 
posing  the  cells to  chemotherapeutic  drugs.  We  have 
analyzed  their  pHi,  Vm,  drug  resistance,  and  other 
traits.  The  data  better  define  the  MDR  protein-medi- 
ated  MDR  phenotype  and  suggest  that  measured  V m 
and  pHi  changes  are sufficient to promote  drug resis- 
tance  and  altered  drug  accumulation  unequivocally 
due to MDR protein overexpression alone. 
MATERIALS  AND  METHODS 
Materials 
2',7'-bis (carboxyethyl)-5, 6-carboxyfluorescein (BCECF), the ox- 
acarbocyanines 3,3'  diethyloxacarbocyanine iodide (diOC2(3)), 
3,3' dipentyloxacarbocyanine iodide (DiOC5 (3)), and 3,3' dihep- 
tyloxacarbocyanine iodide  (DiOC7(3)),  nigericin,  valinomycin 
and the dialkylaminonapthalene pyridinium styryl dye di-4-ANEPPS 
were purchased from Molecular Probes (Eugene, OR)  and used 
without  further  purification. 4-acetamido-4'-isothiocyanato stil- 
bene-2-2'-disulfonic acid (SITS), colchicine, and verapamil were 
from Sigma Chemical Co. (St. Louis, MO), doxorubicin, vincristine, 
and cyclosporin A were from the Memorial Sloan-Kettering phar- 
macy  (New York,  NY),  and  G418  was  from  Life Technologies 
(Grand Island, NY). M1 other chemicals were reagent grade or 
better, purchased from commercial sources, and  used without 
further purification. 
Tissue Culture 
Cell lines stably transfected with hu MDR 1 cDNA were created 
by transfecting a mixture of two plasmid constructs, one harbor- 
ing a neomycin resistance gene (pSVDNAneo obtained from In- 
vitrogen Corp., San Diego, CA), and the other the hu  MDR 1 
cDNA  cloned  behind  a  cytomegaloviral  promoter  (plasmid 
pMDR1),  at  a  1:10  molar  ratio  via  the  CaPO4  precipitation 
method. The  open reading frame of MDR cDNA has been se- 
quenced and, with the exception of a silent Set 180 point muta- 
tion, no differences relative to that published (Chen et al., 1986) 
have been found. Mass populations of LR73  transfectants were 
selected with 500  tzg/ml active G418;  a concentration that did 
not allow negative control transfectants (pMDR1  without pSVD- 
NAneo)  to suiwive. Over 100 G418  resistant colonies were then 
replica-plated in 24-well plates. One well of a pair was grown in 
the presence of 100  ng/ml  doxorubicin. The  second well was 
grown in  the presence of G418 without any chemotherapeutic 
drug.  From an  initial screen of over 100  G418  resistant LR73 
clones, 5 that smwived doxorubicin selection were found to ex- 
press MDR protein (see below). An additional 3 overexpressors 
were found among 35 additional colonies from a second transfec- 
tion. Thus, we find that a low frequency (<10%)  of G418 resis- 
tant clones apparently overexpress significant MDR 1 protein. Af- 
ter screening, cells from the sister "G418-only" wells were propa- 
gated  in  the  presence  of G418  only and  screened  for  MDR 
protein expression via western blot (see RESULTS). These clones 
were, with one exception (see below), never exposed to any che- 
motherapeutic drug before analysis. Cells analyzed for Vm or pHi 
(see below)  were  propagated in  the  absence  of G418  for  not 
more than 10 d. These conditions did not measurably reduce lev- 
els of MDR  protein.  Stock cultures of the  stable  transfectants 
were frozen in liquid nitrogen and resuscitated as needed. 
In one instance, hu MDR 1 clone #27 was exposed to chemo- 
therapeutic drug before analysis (described in the legend to Ta- 
ble II) for the specific purpose of determining how this exposure 
effected the drug resistance profile (see RESULTS). 
LR73  transfectants were  grown  at  37~  in  a  5%  CO,, atmo- 
sphere in Dulbecco's modified Eagle's (DME)  medium supple- 
mented with 10% FCS, 200 U/ml of penicillin, and 100 ~g/ml of 
streptomycin.  For  mass  cell  population V  m measurements  or 
Western  blot  analysis  (see  below),  they  were  harvested  by 
trypsinization, washed, and gently resuspended in fresh media. 
For single-cell photometry analysis of pHi and Vm,  the  cells 
were grown as above but on glass coverslips (18 ram2/0.11  mm 
thick;  Corning Glassworks,  Coming,  NY)  immobilized in  stan- 
dard tissue culture plates with a dab of autoclaved silicon vacuum 
grease (Dow-Corning, Midland, MI). Coverslips were kept in me- 
dia at 37~  and 5% CO  2 until immediately before mounting on a 
perfusion chamber (see single-cell photometry below and Luz et 
al., 1994; Wei et al., 1995). 
Drug Resistance 
Resistance was assayed by colony formation as described (Wei et 
al., 1995).  Surviving colonies >50 cells were scored visually. Plat- 
ing efficiency at each drug concentration was analyzed in dupli- 
cate.  Resistance  was  also  assayed  by growth  inhibition  as  de- 
scribed (Wei and Roepe, 1994). 
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Measurement of anthracycline, vinca alkaloid, or colchicine ac- 
cumulation was essentially as described  (Wei and Roepe,  1994) 
with  some  modifications.  We  assayed  '3H-daunorubicin,  3H-vin- 
blastine, or 3H-colchicine  (New England Nuclear,  Boston, MA) 
accumulation by plating cells in six well plates  (5.0  ￿  104 cells/ 
well initial density),  incubating the  plates in  normal  DME  me- 
dium at 37~  and 5% CO~ (see tissue culture, above) for 3 d until 
they reached 75% confluency, and then exposing them to the :~H 
analogues (50 nM, 200 txCi/mM for :SH-daunorubicin; 50 nM, 75 
IxCi/mM for :~H-vinblastine; 50 nM,  200 IxCi/mM for ~H-colchi- 
cine) for exactly 60 min. Drug-containing medium was then aspi- 
rated; cells were washed once with cold PBS to remove non-inter- 
nalized  drug,  and  cells  then  were  harvested  by  trypsinization. 
Trapped  radioactivity was measured by liquid scintillation spec- 
trometry.  Nonspecific  drug  association  (zero-time  uptake)  was 
measured by incubating an identical number of cells in medium 
pre-chilled to 4~  Cell number was counted using a hemocytom- 
eter, and aliquots of the collected cells were assayed for protein 
content by the Bio-Rad assay  (Bio-Rad Laboratories, Richmond, 
CA). Drug accumulation was expressed as both picomoles drug/ 
microgram total cell protein and nM internalized drug  (see Ta- 
ble I for cell volumes). Protein content per cell was not dramati- 
cally different for the different cell lines. Accumulation was mea- 
sured in triplicate for each cell line in each accumulation assay, 
and the results from three such assays were averaged to yield the 
data shown in results (SE <10%). Data is expressed as a percent- 
age of accumulation, with values for LR73/neo controls defined 
as 100% accumulation (see Fig. 11 in Results). 
Pulse Elevation of  pH  i and Short Exposure Cytotoxicity Assays 
We wished  to  assay chemotherapeutic  drug  resistance for  cells 
with alkaline pH~ that did not express measurable MDR protein. 
Thus, to elevate pH  i of LR73 cells, they were plated at a density of 
10~/100  cm'-' and grown  overnight at 5%  CO,., in  normal  DME 
medium  initially  harboring  44  mM  HCO!~  .  They  were  then 
shit~ed to a  10% CO,., atmosphere, which causes acidification of 
the medium  (see Wei and Roepe,  1994). Milder acidification of 
pH~ accompanies this "CO,, pulse" (see RESUI~TS). Within 36--48 h 
the pH i acidification plateaus, and the cells then nearly recover 
pH i (see RESULTS). If the conditioned cells are then placed back 
in  a  5%  CO,,  atmosphere  in  the  presence  of fresh  pre-equili- 
brated media, pH~ "overshoots" and is ~0.15-0.22 units alkaline, 
relative to normal resting pH i, for ~12-24 h  (see RFSULTS).  Alter 
this time, the cells "re-adapt" and return to normal pHi. 
Because the cells are alkaline for only a  short time, we could 
not measure resistance for alkaline cells via colony formation or 
growth inhibition assays, since these require days of growth in the 
presence of the drugs. Therefore, we de~dsed "short pulse" cyto- 
toxicity assays.  In these experiments, any drug resistance may be 
underestimated,  since  cytotoxic  actions  of  chemotherapeutic 
drngs are not necessarily analogous to their growth inhibito  D, ac- 
tions. MDR protein may confer resistance to both. 
Cells were harvested by nTpsinization, washed in fresh media 
pre-equilibrated in a 5% CO,_, atmosphere, and 1.0 ￿  10  r' aliquots 
were  resuspended in  1 ml of fresh 5%  COe-equilibrated media 
harboring different concentrations of drug  (see  aZSUI,TS).  The 
cell suspensions were tmnbled in eppendorf tubes in a  5% CO.2 
atmosphere,  and  the  cells were  collected,  washed  in  fresh  5% 
CO,e-equilibrated media, and then 2 ￿  104 aliquots were plated ill 
each of four wells of a 96-well plate. The plates were grown for 3 d 
in an atmosphere of 5% CO u, and then stained with clTstal violet, 
after which  the cells were  solubilized,  and dye was quantitated 
with an ELISA reader (see Wei and Roepe, 1994). In separate ex- 
periments we verified that the protein content/cell was the same 
for the different cell preparations. Four determinations at each 
drug  concentration were  then  averaged,  and  the  results  fi'om 
four such assays (16 determinations in all) were averaged (see al,:- 
SUI,TS). 
Similar experiments were also performed at different [K+],,  to 
test the  effect of altered Vm  (see  aEst~I,TS)  on  drug resistance. 
Cells were cultured at 5% CO2, washed in DME media harboring 
either 127 mM Na+/15 mM K + or 127 mM K+/15 mM Na + and 
then tumbled  (as above) in the same media plus varied concen- 
trations of chemotherapeutic drugs.  Cells were  then washed in 
fresh normal media, plated, grown tor 3 d, and stained as above. 
Western Blotting 
Western  blots were  performed  using the  MDR protein-specific 
mAb C219 and the enhanced chemiluminescence detection sys- 
tem  (Amersham Corp., Arlington Heights, IL)  essentially as de- 
scribed  (Wei and Roepe,  1994)  but with some modifications in 
how cell lysates were prepared. Cells were harvested from a  100- 
cm'-' plate  after growth  at 5%  CO,,  to  near confluency, washed 
with PBS, pH 7.3, and stored at -80~  Cells were thawed and lysed 
in  ~200  Ixl cracking buffer  (10%  glycerol,  1%  Triton X-100,  1 
mM PMSF, 10 >g/ml leupeptin, 20 mM HEPES). They were then 
vortexed, incubated at 4~  for 15 rain, and spun in a microcentri- 
fuge  (12,000  rpm)  at  4~  for  5  min.  The  supernatant  was  re- 
moved, and 1 txl was assayed with the Bio-Rad protein assay, with 
BSA as a standard. 100 Ixg of cellular protein was then resolved by 
sodium dodecyl sulfate-PAGE and blotted to nitrocelhflose over- 
night at 40 mA constant current  (Wei and Roepe,  1994). Alter 
Western  blots  were  performed  as  described  (Wei  and  Roepe, 
1994),  the  autoradiogram was  scanned with a  300  dpi scanner 
(Stratagene Inc., LaJolla, CA). The intensity of bands of interest 
were  normalized  to  background  emission  from  the  blot  and 
quantitated with Stratagene densitometry software using an AST 
computer. 
Fluorescence ,Spectroscopy 
Fluorescence  spectra were  obtained with a  Photon TechnoloD, 
International (South Brunswick, NJ) fluorometer interlaced to a 
Dell/433L  computer.  Sample  cuvettes were jacketed  within  an 
aluminum holder, and temperature was controlled by a circulat- 
ing water bath. Cell suspensions were rapidly mixed with a mag- 
netic  stirrer  situated  beneath  the  cuvette.  Excitation/emission 
wavelengths  and  the  other  parameters  of various  experiments 
may be fonnd in the individual figure legends. 
Single-CeU Photometry (SCP) and Measurement of  pH~ 
As  described  (Luz  et al.,  1994; Wei  et al.,  1995),  we  have con- 
structed a single-cell photometry apparatus using a Nikon diaphot 
microscope  and  a  Photon  Technology  alphascan  flnorometer. 
For BCECF experiments a  510-nm dichroic and a  530-nm band- 
pass filter was positioned beneath tim stage,  and the excitation 
monochromator  was  flipped  between  439  and  490  nm  by  the 
compnter  (see Wei et al.,  1995). For carbocymfine experiments, 
we used a  510 dichroic and a  495 high pass filter under the nil- 
croscope stage, and the excitation naonochromator was fixed at 
465 nm. 
Cells were grown on sterile glass coverslips as described above 
and used  >2 but <6 d  after plating. Coverslips were  incubated 
with BCECF-AM in DME media for 30 min belore mounting in a 
perfusion  chamber, which  provided  mfilamellar perfusate  flow 
(Wei et al.,  1995). Aller mounting, cells were continuously per- 
fused with Hank's balanced salt solution (HBSS: 118 mM NaCI, 5 
inM KCI,  10 mM glucose, 24.2 mM NaHCO>  1.3 mM CaCI,.,, 0.5 
mM MgC1,2, 0.5 mM Na,_,HPO.~, 0.6 mM KHePO,; pH 7.33)  equili- 
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perfusate  volume  in  the  perfusion  chamber  was  ~100  ~zl, so 
buffer  over  the  cells  was  exchanged  within  1-2  s.  Uniform 
BCECF staining was verified by monitoring 490-nm excitation in- 
tensity; we did not observe significant differences in BCECF load- 
ing for MDR vs. control transfectants (see RESULTS). All buffers 
harboring HCO~- were continuously purged with 5% CO2  (bal- 
ance air), and pHo was monitored with an electrode. Exposure to 
excitation was limited to the time of data collection to limit pho- 
tobleaching. 
Steady-state pHi was computed by averaging 439/490 nm exci- 
tation for 12-20 individual cells (data collected 1 cell at a  time) 
perfused with HBSS before the same coverslip was exposed to cal- 
ibration  solution  containing  nigericin  (100  mM  KC1, 40  mM 
NaC1,  20 mM HEPES,  1.5 p,M nigericin) equilibrated to various 
pH  (see Fig. 3) and then inserting the averaged value into a qua- 
dratic fit to the calibration solution standard curve.  Calibration 
curves were  obtained  using a  "single  cell" version  of the  K+/ 
nigericin titration approach of Thomas and colleagues (1979) as 
described (see RESULTS and Luz et al.,  1994), and they were gen- 
erated for every coverslip used to measure steady-state pHi under 
physiologic conditions. 
Measurement of Electrical Membrane Potential ( V,n) 
K+/valinomycin null point titration (Laris and Hoffman,  1986), 
using the fast response ratiometric styryl dye di-4-ANEPPS (Mon- 
tana et al.,  1989), was used to quantitatively estimate Vm as de- 
scribed in detail previously (Roepe et al.,  1993; Luz et al.,  1994; 
Wei et al., 1995). We have recently published the results of a dou- 
ble-blind analysis  (Wei  et  al.,  1995)  wherein  V m measured  for 
CFFR overexpressors by electrophysiology techniques  (zero cur- 
rent clamp potential recorded within 10 s of establishing whole 
cell configuration; see  Stutts et al.,  1993)  was  compared  to Vm 
measured  by  our  K+/valinomycin  titration  protocol.  Although 
the values obtained did not agree exactly, significant differences 
in  V,n  between  cell  lines  were  easily  distinguished  by  either 
method,  and  the  general  trend  in  V,n  observed  in  a  series  of 
CFTR  clones  expressing  different  levels  of functional  channel 
was essentially the same via both methods.  Contributions to the 
measured Vm from mitochondria and other organelles as well as 
variability in the concentration of cell-associated dye are less of a 
concern with di-4-ANEPPS measurements, and since it is a fast re- 
sponse  probe,  measurements are  made  in  seconds rather than 
minutes, avoiding altered dye partitioning within the cell during 
the valinomycin titration (see also Roepe et al.,  1993). Thus, any 
postulated pumping of the dye by MDR protein would not, if it 
even existed, bias the measurements. We compensate for the low 
di-4-ANEPPS signal by averaging several traces from multiple ti- 
trations at each [K+],,. As reported previously (Roepe et al., 1993; 
Luz et al.,  1994),  [K+]i does not vary substantially between MDR 
and sensitive cells, thus an average value of 160 mM was used to 
calculate Vm- 
TO  test  conclusions  from  the  di-4-ANEPPS  experiments,  we 
also  measured carbocyanine uptake via single  cell  photometry. 
Coverslips were  perfused with HBSS,  pH  7.30,  as described for 
pH~ measurements above. We then switched to HBSS perfusate 
containing 500 nM diOCz(3), diOCs(3), or diOC7(3 )  and moni- 
tored the increase in cellular fluorescence >510 nm (465-nm ex- 
citation)  while  the  cells were  under  constant perfusion.  Wave- 
length-dependent excitation  and  emission  spectra  in  the  pres- 
ence or absence of cells verified the respective maxima were not 
appreciably shifted by binding to cells. HBSS/carbocyanine solu- 
tions were prepared immediately before perfusion from a  1 mM 
stock made in anhydrous DMSO  and HBSS pre-equilibrated in 
5% COz and to 37~  In some cases, K + was substituted for Na + in 
the HBSS to depolarize cells (see RESULTS). AS pointed out in a 
recent paper by Wadkins and Houghton  (1995)  and as first de- 
scribed by Hoffman  and colleagues  (Sims  et al.,  1974),  longer 
chain length trimethine carbocyanines (diOCv(3)-diOCs(3))  are 
less  responsive  to  membrane  potential  than  moderate  chain 
length carbocyanines  (e.g.,  diOCs(3)),  and in  many cell  types, 
decreasing chain length further does not elicit a more Vm-depen- 
dent  response and may actually decrease  the responsiveness of 
the carbocyanine to V,,, at least as measured by changes in dye 
partitioning  upon  treatment  with  valinomycin.  Redistribution 
should be distinguished from initial accumulation when discuss- 
ing V,,, probes; both "redistribution" upon changing V,~, and ini- 
tial accumulation are Vm dependent, and both responses are dye 
concentration  dependent  (see  Sims  et  al.,  1974;  Roepe  et  al., 
1993; Wadkins and Houghton,  1995). Thus, plotting differences 
in the rate and/or steady state of accumulation of the different 
probes for "matched" cell lines (e.g., derivatives of the same pa- 
rental cell line with similar size)  is a  legitimate complementary 
estimate of any difference in membrane potential (see RESULTS). 
For  cells  with  different Vm,  accumulation  of longer-chain  car- 
bocyanines (relatively non-Vm-dependent at low concentrations) 
should be  similar,  and  relative probe  accumulation  should  di- 
verge as chain length approaches 5  carbons  (i.e., for Vm-depen- 
dent probes). A series of experiments, although tedious, will cor- 
rect for nonspecific effects of dye association that are unrelated 
to  V,n. Accumulation  of  each  carbocyanine  was  measured  for 
each cell line at least four times using four different coverslips, 
and the data were averaged (see RESULTS). 
Measurement of [K+ li 
Cell-associated  K +  was  measured  by  flame  photometry  as  de- 
scribed (Iversen, 1976; Roepe et al.,  1993). After determining in- 
tracellular volume (see below), [K+]i was calculated. 
Measurement of lntraeellular Volume (Vii) 
Total cell volume was calculated after determining the mean par- 
ticle  size  of  cell  suspensions  by  the  single  threshold  Coulter 
method  (Kachel,  1990;  Roepe  et al.,  1993).  Intracellular water 
volume was determined by ratioing 14C-inulin vs.  :~H20  dpm as 
described (Rottenberg, 1979; Roepe et al., 1993). 
RESULTS 
Characterization  of hu MDR 1 Expression and pHi for 
Transfectant Clones 
Table  I  summarizes  characteristics  of a  series of 6  LR73 
pSVDNAneo/pMDR1  transfectants  created  and  iso- 
lated as described  in MATERIALS AND METHODS. Also in- 
cluded  for comparison  purposes  is similar data  for the 
cell line EX4N7  (Gros et al.,  1991), which  is LR73 trans- 
fected with mu  MDR  1  and  a  neo r marker  and  selected 
with G418 only, as well as data for control  transfectants 
(LR73/neo)  which  do  not  express  MDR  1  protein  but 
were  otherwise  treated  identically  relative  to  the  hu 
MDR  1 clones. 
Fig.  1  A  presents  representative  data  from  Western 
blot  analysis  of  MDR  1  protein  expression  in  these 
transfectants  and  shows that we isolated clones with dif- 
ferent  levels  of  MDR  protein  without  subjecting  the 
cells to different  levels of chemotherapeutic  drug  selec- 
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Characteristics of True hu MDRI Transectants 
Fold resistance to 
Relative MDR  Size  V  m 
Cell line  protein  (bma)  pHi  (+ -<4 mV)  Dox  Vncr  Col 
LR73  0  12.04+0.27  7.14-+0.03  45  --  --  -- 
LR73/neo  0  11.91 -+0.19  7.16-+0.03  46  --  --  -- 
1,R73/21  1  11.87-+0.74  7.38-+0.06  38  1.2  2.1  1.5 
LR73/24  11.7  11.91 -+0.11  7.48-+0.04  24  2.8  10.2  4.1 
LR73/27  9.7  11.86-+0.26  7.51 -+0.05  26  2.7  9.5  3.2 
LR73/71  2.7  11.72-+0.06  7.42-+0.04  29  1.6  3.4  3.1 
LR73/88  2.1  11.85-+0.21  7.40-+0.03  31  1.9  2.6  3.3 
LR73/95  2.8  11.57-+0.17  7.37+0.05  35  2.1  3.4  1.8 
EX4N7 
(LR73/mu MDR 1)  5.1  N.D.  7.31-+0.04  23  3.6  9.2  4.5 
Relative MDR protein (via densitomeny), size -+ SD (by the single threshold Coulter method), phi -+ SD (by SCP), Vn, -+ SE (by K+/val  titration with di- 
4-ANEPPS; see Roepe et al., 1993; Luz et al., 1994), and drug resistance (by colony  tbrmation; see Wei et al., 1995) for LR73-derived  hu MDR 1 transtbc- 
tants used in the present work, as well as parental LR73 cells  and a negative  control transfectant  also selected with G418. Relative MDR protein is the aver- 
age of three densitometric determinations from three Western blots; note clone #21 is assigned a value of 1. Fold-resistance  was determined by either 
growth inhibition or colony  formation assays and ratioing ICr,0s that were calculated by exponential ties to the data (R  z > 0.92 in each case, see Wei el al., 
1995 and MATERIALS  AND METHODS). Data shown is the average of two determinations (Wei et at., 1995). N.D. denotes not done. 
tion. Overexpression of nm MDR 1 protein may be un- 
stable  in some  transfectants; that  is,  EX4N7  cells cul- 
tured for several months in the presence of G418 even- 
tually lose  mu  MDR  1  protein  (Luz  et  al.,  1994).  As 
shown in Fig.  1 B, we again find this to be the case for 
some,  but  not  all,  hu  MDR  1  transfectants. As  some 
clones are passed in the presence of G418, overexpres- 
sion of MDR protein decreases,  and eventually disap- 
pears after 14-21 passages. Thus, most subsequent work 
was performed with cell lines exhibiting stable overex- 
pression  (e.g.,  clones #24, #27,  and #95),  and overex- 
pression levels were routinely checked every 6-10 pas- 
sages.  We  do  not find  that  high  level  expressors  are 
necessarily less  stable  with  regard  to  expression  over 
time, in fact,  clones #24 and #27 exhibit a  very stable 
phenotype (see Fig. 1 legend). 
Levels of overexpression varied from very mild (#21) 
to quite impressive; clones #24 and #27 exhibit levels of 
expression that are higher than those found in MCF7/ 
ADR and 8226/Dox40, breast carcinoma and myeloma 
cells selected with anthracycline that are ~100- and 65- 
fold  resistant to  doxorubicin, respectively  (Fig.  1  C). 
Expression in #27 and #24 is comparable to that found 
for LR73/1-1 cells, which are Chinese hamster ovai  T fi- 
broblasts transfected with murine MDR 1 and selected 
with  50  ng/ml  vinblastine to  ~100-fold  resistance  to 
the  antimitotic  (Gros  et  al.,  1991)  and  close  (within 
twofold)  to  the  levels  found for  DC3F-ADX  (Biedler 
and Riehm,  1970),  a  Chinese hamster lung fibroblast 
selected  to  10,000-fold  resistance  to  actinomycin  D 
(Fig. 1 C). Thus, comparing these data to data in Table 
I  indicates high levels of drug resistance in MDR cells 
are  related more  to  drug selection than to  MDR pro- 
tein overexpression. 
Notably, all hu MDR  1 clones exhibit significant in- 
tracellular alkalinization (between 0.21  and 0.35 units) 
relative to control transfectants (Table I). The present 
data showing alkalinization in all six independently de- 
rived clones,  along with  a  qualitative relationship be- 
tween alkalinization and MDR protein expression  (see 
DISCUSSION)  shows that hu MDR 1 protein overexpres- 
sion  typically promotes  intracellular alkalinization in 
LR73  cells.  Since  it  has  been  proposed  that  the  ace- 
toxymethyl ester analogues of probes we  have used to 
measure pH i might be "pumped" by the MDR protein 
(Homolya et al.,  1993), we have thoroughly examined 
this  possibility. Fig.  2  presents  representative BCECF- 
AM  loading and BCECF washout data for  hu  MDR  1 
and control transfectants and documents that BCECF- 
AM or BCECF pumping does not occur in these trans- 
fectants. Furthermore, calibration curves generated as 
described in MATERIALS AND METHODS reveal that the 
pHi-dependent behavior of BCECF is virtually identical 
in the different cell lines (Fig. 3). That is, even though 
there  are  slight  differences  in  the  absolute  value  of 
439/490  nm  BCECF  excitation  at  various  pHi,  the 
shape and slope of the  439/490 nin excitation vs.  pH~ 
cmwes for the different cell lines are indistinguishable. 
Even  if we  disregard  the  data  in  Fig.  2  and  assume 
BCECF or BCECF-AM is pumped by MDR protein, this 
pumping function does not compromise our ability to 
obtain accurate pHi. 
Examination of H + Excretion and pH,/pH  o Relationships 
with or without HCO~- 
In  culturing drug-selected  MDR  cells  over  the  years, 
many investigators have noticed that growth media har- 
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500 
FI(;URE 1.  Western blot analysis of hu MDR 1 transfectants using 
the MDR protein-specific mAb C219.  The prominent band that 
migrates at 170 kD is hu MDR 1 protein. In A, B, and C, each lane 
harbors 100 btg total cellular protein, as measured previously (Wei 
and Roepe,  1994) using BSA as a standard. In A, 8 LR73/tm MDR 
1 clones are compared to a negative transfectant control. Lane i is 
a LR73/neo control, and lanes 2-9are clones #6, 8, 24, 27, 71, 95, 
88, and 21, respectively. In B, two clones (#88, #71) are assayed for 
relative MDR overexpression after multiple  passages  in  the con- 
stant presence of G418 only. Lane 1 is a negative transfectant con- 
trol,  lanes  2-4  and  5-7 are  the  two clones passed  4,  10,  and  18 
times in the constant presence of G418. Similar loss of MDR pro- 
tein is seen in other clones (not shown) making it unlikely that loss 
is  chromosomal  integration  site  specific.  In  the  present  work, 
clones #24,  27,  and  71  exhibited very stable overexpression  (no 
loss detected within 15 passages). Clones 88, 95, and 21  exhibited 
stable overexpression for at least 5-6 passages. In 6, expression of 
hu MDR 1 protein in four pure transfectants (including clones #27 
and 24, lanes 2 and 3,  respectively) is compared to expression of 
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FIGURE 2.  Demonstration that the rate of passive leak of BCECF 
under constant perfusion and the efficiency of BCECF loading (via 
conversion  of  BCECF-AM)  is  virtually  identical  for  hu  MDR  1 
(dashed  line)  and  control  transfectants  (solid  line)  used  in  the 
present work.  Coverslips were loaded in the presence of BCECF- 
AM for 30 rain as described in MATERIAI.S AND METHODS, and then 
placed in the single-cell photometry perfusion chamber. Perfusion 
with HBSS (37~  pH 7.33) was initiated, and both 439/490 nm ex- 
citation ratios (A) and 490 nm excitation (>530 nm emission) (B) 
were recorded tbr single cells. The 439/490 nm trace, which is pro- 
portional to pH i, (A) is quite stable nnder constant perfusion dur- 
ing the  time course of our experiments.  In contrast to previous 
studies  that used selectants  (Homolya  et al.,  1993), we  find that 
MDR  and  control  transfectants  convert  very  similar  levels  of 
BCECF-AM  (early  time,  B)  in  sinfilar time  and  exhibit virtually 
identical rates of BCECF leak  (B)  that varies between  1 and 5% 
per h. In well over 100 individual experiments, no statistically sig- 
nificant difference in the level of BCECF-AM loading has been ob- 
served for these MDR  transfectan~s relative to the parental cells. 
Along with the observation that the K+/nigericin titration curves 
for the different cell lines are snperimposable  (see Fig.  3)  these 
data argue that there is no interaction between BCECF or BCECF- 
AM and the MDR 1 protein. 
boring phenol red turns a more yellow color, relative to 
the media for control drug-sensitive cells, perhaps indi- 
cating a  greater  production  of acid  by the  MDR cells. 
Since  our clones  have  alkaline  pHi  (Table  I),  perhaps 
one explanation for both observations  is increased  cel- 
lular H + effiux. We quantified acid production by ratio- 
ing DME  media  absorbance  at 560 and 421  nm at dif- 
human, hamster, and mouse MDR proteins in MCF7-ADR human 
breast carcinoma (lane 5) and 8226/Dox40 human myeloma (lane 
8) cells, DC3F-ADX chinese hamster lung (lane 6) cells, and LR73 / 
1-1  (lane  7)  cells,  respectively.  Levels of expression  in several ot 
our pure transfectants are comparable to the levels recorded for 
chemotherapeutic drug selected (MCF7-ADR, 8226/Dox40, DC3F- 
ADX) or selectant (LR73/1-1) cell lines, which exhibit particularly 
high levels of MDR protein overexpression. 0.35 
0.30' 
_E  0.25 
"-  0.20 
,q, 
0.15  ..... 
6.6  6.8  7.0  7.2  7.4  7.6  7.8 
pHi 
FmURE 3.  Representative calibration solution standard curves for 
control LR73/neo and the 6 different MDR transfectant cell lines 
summarized in Table I, generated as described in Methods and 
Lnz et al., 1994. Each curve is fit to a 2nd order polynomial, h"-' > 
0.97 in each case. Note that behavior of BCECF over the full range 
of its pH dependent response (pH 5.8-8.0) is sigmoidal in shape 
and that the quadratic fit (which represents approximately one 
half of the full titration curve) should not be used to calculate pH  i 
values that lie outside the actual experimental data points. Stan- 
dard error for each point is <6%, but the error bars are omitted 
for clari~'. Note that although absolute values of 439/490 nm exci- 
tation at a given pHi may differ for different cell lines (or even dif- 
fierent coverslips of the same cell line, data not shown), the shape 
and slope of the calibration curves are virtually identical, illnstrat- 
ing similar pHi-dependent behavior of trapped BCECF |or the dif- 
ferent cell lines. 
ferent days' growth  (Fig. 4). To correct for mild differ- 
ences  in  growth  rate,  data  is  plotted  vs.  cell  number. 
The  inset to Fig. 4  shows  a  calibration cmwe for DME 
media titrated to different pH. We do not measure sig- 
nificantly increased production of H + for cultures of ei- 
ther  clone  #24  (Fig.  4,  diamonds)  or  clone  #27  (not 
shown),  relative to control cells (Fig. 4,  square.s).  Based 
on  this  observation,  and  estimation  of the  change  in 
pH,, expected for a  given increase in the rate of H + ef- 
flux,  (see legend to Fig. 4), we conclude that alkaliniza- 
tion of the MDR clones is not likely due to an increased 
rate of H + effiux from these cells. 
To further examine pHi regulation, we measured pHi 
at a variety of pH,, while cells were perfused with buffers 
with or without variable [HCO:~]  (Fig. 5). We have pre- 
viously observed  (Roepe  et al.,  1993;  Luz  et al.,  1994; 
Roepe et al., 1994)  that cells overexpressing MDR pro- 
tein  exhibit  altered  HCO~-dependent  pHi  regulation 
(i.e.,  reduced  C1  /HCO:~  exchanger  activity).  As 
shown,  pHi/pH,,  relationships  obtained  in  the  pres- 
ence vs. absence of HCO:~  are different for the control 
cells,  whereas  they  are  much  more  similar  for  clone 
#27.  These  data  suggest  alkalinization  for  the  MDR 
clones may be, at least in part,  due  to perturbation  of 
HCO :~-dependent mechanism (s). 
Electrical Membrane Potential Alterations 
Along with alterations in phi, importantly, all hu MDR 
1  clones were found  to be depolarized  (Table I), The 
decrease in Vm was quantitatively estimated to vary from 
8  to  22  mV via K+/valinomycin  titration  as described 
(Roepe et al., 1993; Luz et al., 1994).4 
To  further  test for differences in  membrane  poten- 
tial, we  analyzed  the  rate  and  steady state  of oxacar- 
bocyanine  uptake  for  attached  cells  under  constant 
perfusion.  Members  of the  diOC,,(3)  series of oxacar- 
bocyanines  differ in  their  response  to  membrane  po- 
tential but only slightly in size  (Sims et al.,  1974; Wad- 
kins and  Houghton,  1995),  and  not  at all in  terms  of 
fluorescence  excitation/emission  wavelengths.  Thus, 
analysis of the  relative  uptake  of a  series  of the  com- 
pounds  (see MATERIALS AND METHODS)  offers a  way to 
analyze Vm and control for nonspecific effects. 
Fig.  6  A-C  compares  accumulation  of  diOC7(3), 
diOCs(3),  and  diOCe(3),  respectively,  for  LR73/hu 
MDR 1 #27  (dashed lines, bottom trace in each compari- 
son)  and  a  control  LR73  transfectant  (solid  lines,  top 
trace in each comparison), and Fig. 6 D shows accumu- 
lation of the well known V., probe diOCs(3)  for the se- 
ries  of clones  listed in  Table  I.  The  inset  to  Fig.  6  D 
compares diOC~(3)  uptake for control cells in the pres- 
ence of normal HBSS  (t0p solid line)  vs. control cells in 
the presence of HBSS containing 150 mM K +  (high K + 
HBSS; bottom dashed line). Since high  [K  + ],, will depolar- 
ize  the  plasma membrane  of these LR73  cells  (Luz  et 
al.,  1994),  data in  the  inset demonstrate  the  ability of 
the  single-cell method  to distinguish between  cells ex- 
hibiting  significantly different V,~.  Clearly,  clones  ex- 
hibiting  high  levels  of  MDR  protein  expression  and 
substantial  depolarization via  the  K+/valinomycin  de- 
termination  (Table  I)  accumulate  oxacarbocyanines 
that  are  more  responsive  to  V,,  (diOC~(3)  and 
diOC~(3),  Fig.  6  B  and  C)  at a  reduced  rate  and  to  a 
much  lower  steady state,  relative  to  the  control  cells, 
but accumulate diOC7(3)  (Fig. 6 A), which does not re- 
spond  to  Vm  vex,/  efficiently  at  these  concentrations 
(see Sims et al.,  1974;  Wadkins and  Houghton,  1995), 
similarly relative to control cells. Also, with one excep- 
tion (clone #88)  the relative uptake of diOC~,(3) for the 
tRepresentative K+/valinomycin  titration traces  for I.R73 cells and 
pure  mu  MDR  1/LR73  transfectants  may be found  in  I.uz  et al. 
(1994); we compensate tbr the low di-'4-ANEPPS  signal by averaging 
at least three traces at each [K  +  ] (see Luz et al., 1994 and Measuremet~t 
oJ Membrane Electrical Potential in MATERIALS  AND MErHODS).  A do/I- 
hie-blind comparison of electrophysioh)gic  and our K+/valinomycin 
titration methods  has  recently t)een  published  (Wei et al.,  1995). 
Note that all the cell lines examined are derived t}om a single isolate 
of the parental LR73 cell line, have ve  D' similar size (Table 1)  and 
have V,,, that is dominated by K  + conductance (not shown, see Roepe 
et al., 19.03). Thus, the most reasonable explanation tor substantially 
different K~/valinomycin null points (Table 1) is different V,,,. 
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FIGURE 4.  Plot of DME culture  medium  pH vs. cell densi W for 
growing cultures of control (squares) and MDR 1 (clone #24) trans- 
fectants  (diamonds). Data are fit to exponential equations,  (R'-' > 
0.91 in each case), and are representative of three separate experi- 
ments. The inset shows the change in 560/421  nm absorbance for 
DME media  (equilibrated with 5%  CO.,  and  to 37~  titrated  to 
different pH via addition of 5 Ixl aliquots of 0.10 N HC1 (e.g., addi- 
tion of 0.50 mM H + between each point). Data is fit to a logarith- 
mic equation, R'-' >  0.96. From this calibration curve we can conve- 
niently calculate pH  o of the culture medium by visible absorption, 
as well as  the  medium  buffering  capacity  at various  pH,,,  since 
known amount.s of HC1 were added  (13i = ApH/2x[H+]). Even al- 
lowing for DME buffering capacity, ifMDR protein directly or indi- 
rectly translocated  H + at a  turnover greater than  ~10  H+/MDR 
protein/s, we should measure a faster acidification for the trans- 
fectant culture medium. Using the data in the inset, we calculate 
the buffering capacity of DME media (between pH 7.33 and 6.93) 
to be 9.8 raM. We estimate that the minimal pH change that would 
be reliably detected under these experimental conditions is about 
0.05 U/d, and to produce this change the MDR protein present in 
10  ~ cells would need to extrude on the order of 10 Is H+/d. Assum- 
ing a  reasonable  site density tor MDR protein, we can eliminate 
models that  envision MDR protein  directly or indirectly translo- 
cates more than ~10 H+/s. Thus, ifMDR protein is (or stimulates) 
an H + ATPase, or promotes H + effiux some other way, it has vely 
slow turnover at the pH  i listed in Table I. 
different  clones  (Fig.  6  D)  appears  to  follow the  same 
trend  as  V,,  determined  by  K+/valinomycin  titration 
(Table I). We have no simple explanation  for the some- 
what  unusual  accumulation  for  clone  #88,  which  con- 
sistently  plateaued  slowly,  but  always  remained  below 
accumulation  for the controls. 
Mthough  the  diOCr,(3)  accumulation  method  is  by 
no  means  as  quantitative  as  null  point  titration,  these 
data  are  consistent  with  decreased  V,,  for  the  MDR 
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FIC.URE 5.  Plot of the relationship between pH~ and pH. for con- 
trol  (A) and hu MDR 1 clone #27  (B)  transfectants.  The pHi was 
measured under constant perfusion by SCP as described (see MA- 
TFRIALS AND  METHODS)  and  pH,,  (+0.03  U)  was  measured  for 
equilibrated  perfusate with a  pH  electrode. Cells were  pelfused 
with  buffer for  10  min  before initiating  the  measurements.  For 
each coverslip, we either started with high pH perfusate and pro- 
ceeded to lower pH, or visa versa, collected pH~ for 20 cells at each 
pH  (with  10  min  equilibration  time between  buffers)  and  then 
computed a standard  curve using the same coverslip (see Fig. 3). 
We noticed slight differences in pHJpH,, relationships depending 
upon whether perfusate went from high to low or low to high pH, 
but compensated for this slight variation by averaging the results 
from six different experiments with six different coverslips to com- 
pute pHi (+_0.07 U) at each pH. (+_0.03 U, error bars omitted for 
clarity). The open symbols represent data collected under HCO:~- 
free conditions  (perfusion with HEPES buffered saline; 145  mM 
NaC1, 5 mM KC1, 10 mM glucose, 1.3 mM CaC12, 0.5 mM MgCI~, 20 
mM HEPES adjusted to various pH), and the closed symbols repre- 
sent data collected during constant perfl~sion with HBSS adjusted 
to different pH by adjusting HCO~ concentration in the medium 
(at fixed 5% COL_,). The HCO:T concentrations were 10, 24.2, 50, 
and 75 mM at pH 6.92, 7.30, 7.57, and 7.93, respectively, and tonic- 
ity of the medium was kept constant (relative to normal HBSS) by 
either addition of 14.2 inM or withdrawal of 25.8 or 50.8 mM NaC1, 
respectively, along with addition of reduced or increased NaHCO:),, 
respectively (see MATERIALS  AND METHODS). Reduction of CI- con- 
centration  by 50 mM for HBSS (via substitution  with glutamate) 
does not in and of itself lead to significant changes in pH, for these 
cells over the time course of the measurements (not shown). 
is related  to relative MDR protein  overexpression.  One 
could  conceivably argue  that  decreased  diOC2(3 )  and 
diOCs(3)  uptake  is  due  to  outward  pumping  of  the 
compounds  by MDR protein, but it would be surprising 
if MDR  protein  pumped  compounds  as  structurally  di- 
verse as  diOC2(3)  and  vincristine,  but  not compounds 
as  similar  as  diOCT(3)  and  diOC~(3).  Considering  all 
the  data  together,  decreased  carbocyanine  uptake  due 
to lower V,, is a  much  more  logical explanation. 
Resistance  of the Clones to Chemotherapeutic Drugs and 
Chemoreversal 
The  clones were also analyzed for resistance  to the che- 
motherapeutic  drugs  doxorubicin  (Dox),  vincristine 
(Vncr),  and  colchicine  (Col)  (Table  I).  As  previously 
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FIOURE 6.  Comparison  of the  accumnlation  of diOC7(3)  (A), 
diOC:,(3)  (B), and diOC2(3  )  (C)  for control cells (to[) solid  trace, 
each comparison) vs. hu MDR  1 transfectants (clone #27;  bottom 
dotted  trace, each comparison). Data shown is the average of at least 
four  traces  obtained  with  different coverslips.  In  these  experi- 
lnenLs, cells remained attached to solid substrate and carbocyanine 
uptake was monitored by SCP far cells under constant perfltsion 
(see MATERIALS  AND METHODS). Cells were initially perfused with 
normal HBSS  for  10  min  (not shown),  and  then  perfusate was 
switched to HBSS containing 500 nM carbocyanine (the sharp de- 
parture from the baseline denotes addition ot the probe). Pet~u- 
sate flow rate was constant at 5 ml/min. In (D), diOC:,(3) accumtfia- 
tion is compared for the series of clones expressing different levels 
of MDR protein. Traces shown  are the average of at least four ex- 
periments  using  four  different  coverslips.  The  inset  sho~,:s 
diOC~(3)  accumulation  for  control cells perfnsed with  normal 
HBSS (to]), solid line)  or HBSS harboring a high (150 raM) concen- 
tration of K  + (bottom,  dashed  trace) for 5 min before switching to 
perfusate harboring 500 nM diOCs(3), and demonstrates that the 
SCP method easily distinguishes between high and low V,,. Traces 
shown  are the average of at least three experiments performed 
with different coverslips. 
observed for 3T3/mu  MDR  1  infectants  (Guild  et al., 
1988)  or  mass  populations  of pure  LR73/mu  MDR  1 
transfectants  (Devault and Gros, 1990),  drug resistance 
exhibited by these pure hu MDR  1 transfectants is low 
compared  to MDR  1 overexpressing cell lines that are 
selected  or  maintained  with  chemotherapeutic  drugs 
(see INTRODUCTION  and Fig. 1 O. Thus, data in Table I 
and Fig. 1 Cindicate that exposure to chemotherapeu- 
tic drugs must significantly perturb  the resistance pro- 
file unequivocally attributable to MDR protein overex- 
pression. 
To  test this idea further,  clone #27 was grown in the 
presence of either doxorubicin  (cell line 27D500),  vin- 
cristine  (27V500),  or  colchicine  (27C500)  over  a  pe- 
riod  of several weeks  to  generate  three  derivative cell 
lines  (see  Table  II  legend).  These  three  "selectants" 
were  then  assayed for drug  resistance  and  for relative 
MDR  protein  expression as described in  Fig.  1  (Table 
II). Interestingly, growth in the presence of either doxo- 
rubicin  or colchicine not  only increased  resistance  to 
the  "selecting agent,"  as would  be  anticipated,  but  in- 
creased  resistance  to  the  other  two  drugs  as  well.  In 
contrast,  growth  on  vincristine  did  not  increase  resis- 
tance  to  the  other  drugs  as  significantly. Relative  ex- 
pression  of MDR  protein  increased  only slightly  (10- 
30%)  for the selectants relative to the transfectant  (Ta- 
ble  II).  For  each  selectant,  the  "resistance  profile" 
(rank  of  preferential  resistance  to  various  drugs) 
changes. For example, 27C500 was similarly resistant to 
the three drugs, whereas 27D500 was clearly more resis- 
tant  to  Dox,  and  clone  #27  grown  in  the  absence  of 
chemotherapeutic  drug more resistant to Vncr. 
Studies have  shown  that several compounds,  includ- 
ing  the  channel  blocker  verapamil  and  the  immuno- 
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Relative Resistance of Selectants 
Fold resistance to 
Cell line  Dox  Vncr  Col  Relative MDR protein 
LR73/#27  2.7  9.5  3.2  9.7 
27D500  21.1  15.3  10.2  12.2 
27V500  6.0  13.2  3.5  11.3 
27C500  12.2  11.5  9.6  11.2 
Fold resistance to doxorubicin  (dox), vincristine (vncr); and colchicine 
(col)  for  three  drug exposed derivatives  ("selectants")  of clone #27,  as 
well as relative MDR protein expression (relative to clone #21, see Table 
II). The three se]ectants were produced by growing clone #27 cells in the 
presence of either 150 nM Dox, Vncr, or Col for 2 wk, and then 3 wk more 
in the  presence of 500  nM  respective drug.  These  "drug conditioning" 
conditions should  be  distinguished from  formal  selection with chemo- 
therapeutic drug. Resistance was analyzed by growth inhibition assays (see 
MATERIALS AND METHODS) and relative survivability  at 6 concentrations of 
drug was analyzed in  triplicate  (see Wei and  Roepe,  1994;  SE  for each 
point <5%). After fitting survivability  curves (e.g. as shown in Fig. 7) to an 
exponential (Wei et al., 1995; each fit R 2 <  0.92) IC50 for a given drug was 
calculated, and ratioed vs. 1Cs0 determined for LR73/neo to compnte fold 
resistance. Relative MDR protein expression is the average of two densito- 
metric  scans from  a  Western  blot  performed  as  described in  Methods; 
both LR73 #27 and LR73/neo were also resolved on this gel as an internal 
calibration. 
suppressive  agent cyclosporin A, act as  chemoreversal 
agents, meaning they reverse the drug resistance exhib- 
ited by MDR cells (Ford and Hait, 1990). Reversal of re- 
sistance  at  nontoxic  doses  of chemoreversal  agent  is 
not typically complete, and the level of drug resistance 
mediated by MDR protein is low (Table I). Also, these 
compounds compete with chemotherapeutic drugs for 
nonspecific  membrane  association  (Wadkins  and 
Hougton, 1993), which might confer chemosensitizing 
ability independent of MDR protein. For these reasons 
it  is  unclear  whether  chemoreversal  agents  reverse 
MDR  protein-mediated  MDR.  Therefore,  we  tested 
whether the drug resistance in our transfectants was re- 
versed by verapamil and cyclosporin A. Fig.  7  demon- 
strates  that,  indeed,  these  compounds  resensitize 
LR73/hu MDR 1 #27 to the toxic effects of vincristine. 
Similar results were obtained for two other clones exhib- 
iting similar levels of hu MDR 1 protein overexpression 
(data not shown). However, importantly, cyclosporin A 
was found to be toxic above 2 txM, thus apparent com- 
plete "reversal" at 2.5 IxM is due to a combination of re- 
versal  effects  and  cyclosporin  toxicity.  Similarly,  we 
could not demonstrate complete reversal with nontoxic 
levels of verapamil (< 10 txM). 
Drug Resistance for Fibroblasts with Alkaline pHi or Exposed 
to High [K+]o 
In testing the pHi/Vm altered partitioning model, it is 
not  only critical  to  determine  how much  drug  resis- 
tance is  explicitly due  to overexpression of MDR pro- 






1  10  100  1000  10000 
[Vincristinel, nM 
FIGURE 7.  Relative sm-vivability  via growth inhibition  (see MATE- 
RIALS  AND  METHODS)  VS,  increasing concentrations  of vincristine 
for clone #27 (solid circles) or control transfectants (open circles) in 
the absence of modulators, or clone #27 analyzed in the presence 
of either 1 p~M (open triangles) or 2.5 p~M (0pen squares) cyclosporin 
A, or 1 p~M (closed triangles) or 5 p~M ( dosed squares) verapamil. Very 
similar data was also obtained for clone #24 (not shown). Nearly 
complete "chemoreversal" is seen at nontoxic levels (1 ixM) of cy- 
closporin A, but sensitization to an extent greater than the trans- 
fectant control is seen at 2.5 txM due to toxicity  of cyclosporin A at 
this concentration  (hence open squares to the left of the curve for 
the control). 5 IxM verapamil provides for 60-70% reversal of the 
resistance due to MDR 1 protein overexpression. 
rein, but also whether the extent of alkalinization and/ 
or depolarization  observed is  sufficient to lead  to  the 
measured drug resistance. Since drug resistance is typi- 
cally assayed over days in cell culture, but most manipu- 
lations  of pHi  and Vm  are  only reliable  for minutes/ 
hours (or are toxic thereafter)  this is challenging. Anal- 
ysis of CFTR clones that showed depolarization is suffi- 
cient  to  cause  low-level  MDR  has  recently  been  re- 
ported (Wei et al.,  1995). To test whether elevated pHi 
is  sufficient to cause  MDR,  and  to further test  the  ef- 
fects of depolarization, we devised a short exposure cy- 
totoxicity assay (see MATERIALS  AND METHODS)  for  con- 
trol  cells not expressing MDR protein but elevated  in 
pHi via growth at different percentages of CO9, or de- 
polarized by exposure to high [K+]o (see Fig. 6 D, inset). 
Fig. 8 presents pH  i data for LR73 cells grown for 48 h 
at 5% CO2, followed by 72 h at 10% CO2, and then 72 h 
more at 5% CO  2. Initial exposure of LR73 cell cultures 
to higher percentages of CO,,  (at fixed  HCO  3 in the 
medium)  leads to fast acidification of pHo as reported 
(Wei  and  Roepe,  1994)  and  concomitant, but  not as 
pronounced,  acidification  of pH  i  (Fig.  8).  After  pH  i 
plateaus during high percent CO2 "conditioning," and 
305  HOFFMAN  ET AL. 5% CO2 
10% C02  5% CO2 
7.4 I 




=  24 hrs 
FIGURE 8.  Alterations in pH  i for LR73 cells upon pulsing growing 
cells with different percentages of CO>  Cells were grown as de- 
scribed in  methods, pH  i was  measured for  these cells approxi- 
mately every 24  h  in triplicate (at the pH,,  of the media under 
these conditions, see Wei and Roepe [1994]), and the data aver- 
aged (the Xshown in this plot _+0.04 pH U). We note a small yet 
reproducible transient elevation in pH i for cells at 5%  CO 2 after 
they are stimulated to presumably increase the rate of H + removal 
via growth under acidic (10%  CO2) conditions. Dramatic overex- 
posure of Western and Northern blots reveals that no induction of 
MDR protein or mRNA expression occurs tinder these conditions 
(not shown, see Wei and Roepe, 1994). 
assuming the  density of the  culture is kept subconflu- 
ent,  the  cells  "readjust"  their  pHi  homeostasis  and 
nearly  recover  normal  pHi.  When  these  conditioned 
cells  are  suddenly  transferred  back  to  5%  CO 2  and 
fresh,  pre-equilibrated  media  is  added,  pHi  "over- 
shoots"  for  12-24  h,  and  theh  re-normalizes  once 
again. Thus,  a window of alkaline pHi is available for a 
short  period  of time  in  the  absence  of MDR  protein 
overexpression. 
To  test whether  these  alkaline cells were  drug resis- 
tant,  we  performed  short  exposure  cytotoxicity assays 
(see MATERIALS AND METHODS)  (Fig. 9, A-C).  Overex- 
posure of Western and Northern  blots revealed no in- 
creased MDR protein or mRNA overexpression in the 
cells after  manipulating percentage  of COe  (data  not 
shown, see Wei and Roepe, 1994). Nonetheless, cells el- 
evated  in  phi  by 0.16-0.24  units  did  exhibit low,  but 
measurable, resistance to doxorubicin, vincristine, and 
colchicine.  Resistance  to  doxorubicin  and  vincristine 
was  higher  (approximately four- to fivefold and  three- 
to  fourfold,  respectively)  relative  to  colchicine  resis- 
tance  (approximately twofold). 
The fold-resistance exhibited by these alkaline cells is 
slightly lower  (on  average)  than  the  resistance  of the 
two  clones  exhibiting  particularly  high  levels  of  hu 
MDR 1 protein expression  (clones #24 and 27, see Ta- 
ble I)  yet is comparable  to  the  resistance exhibited by 
the lower-level expressors. However, we do not measure 
significant alterations in Vm for CO  2 pulsed cells  (data 
not shown),  and a  variety of data  (reviewed in Roepe, 
1995)  suggest both decreased Vm and elevated pHi con- 
tribute  to  MDR  protein-mediated  drug  resistance. 
Thus, one key element of the MDR phenotype is absent 
for these  COz  pulsed cells. Also, due  to  the  nature  of 
the assay (see MATERIALS AND METHODS)  these levels of 
resistance may be underestimates. 
Similar cytotoxicity assays were  performed  for LR73 
cells resuspended  in  DME  media containing  different 
[K+]o  (Fig.  10).  LR73  cells are depolarized  (cf., Fig. 6 
D,  inset)  in media containing  15 mM Na+/127  mM K + 
(dashed lines,  Fig.  10).  Fig.  10 shows  these  depolarized 
cells (estimated 25 mV Vm by comparing data in Table I 
and Fig. 6  to similar diOCs(3)  data for cells exposed to 
high K + DME for similar time, not shown)  are also re- 
sistant  to vincristine  (three- to fourfold),  doxorubicin 
(three-  to  fourfold),  and  colchicine  (~l.5-fold).  The 
resistance is not due to pHi or V~ changes secondary to 
treatment  with  high  [K+]o  (see  legend  to  Fig.  10). 
These  data agree with other studies  (Wei et al.,  1995) 
that measured  mild drug resistance for stably depolar- 
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FIGURE 9.  Relative  resistance to 
Vncr  (A), Dox  (B),  and Col  (Q 
for cells pulse elevated in pH  i as 
described in Fig. 8. In these exper- 
inaents, cells were hmwested either 
before CO2 pulse treatment (open 
symbo& solid line~) or at the peak of 
pH  i  elevation  (~12-15  h  after 
shifting back  to  5%  CO2).  They 
were washed and gently tumbled 
in  eppendorf tubes with  various 
concentrations  of  drug  as  de- 
scribed in  MATERIALS  AND  METH- 
ODS.  Cells were then stained after 
3 d growth at 5% CO  2. The results 
fi'om 4 such assays (16 dmermina- 
tions at each drug concentration) 
were  then  averaged  and  are 
shown -+SE. 
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FIGURE 10.  Relative  resistance 
to Vncr  (A),  Dox  (B),  and  Col 
(C) for LR73 cells depolarized by 
suspension  in  medium  contain- 
ing 127 mM K  § (see Fig. 6 D, in- 
set). In  these  experiments, cells 
were harvested, washed in fresh 
DME  media  containing  either 
127  mM  Na  +  and  15  mM  K  + 
(solid lines) or 127 mM K  + and 15 
mM Na  + (dashed lines) and resus- 
pended in the same media plus 
various  concentrations  of  drug 
(see  MATERIALS  AND  METHODS). 
The results from 3 assays (12 de- 
terminations at  each  drug  con- 
centration)  were  then  averaged 
and are shown  +_SE. As demon- 
strated elsewhere  (Roepe et al., 
1994) the presence of high [K+],, 
for LR73  cells does not change 
steady state phi substantially, and 
we do not measure significantly 
different Vi for these high [K+],,  - 
treated LR73  (data not shown), 
thus the most straightforward in- 
terpretation is that mild drug re- 
sistance in  these cells is  due  to 
membrane depolarization. 
Drug Accumulation 
Another feature of the MDR phenotype is altered che- 
motherapeutic  drug  accumulation.  We  measured  the 
accumulation  of  3H  derivatives  (see  MATERIALS  AND 
METHODS)  of anthracycline (Fig. 11, open bars), vinca al- 
kaloid  (dotted bars),  and  colchicine  (solid bars)  for two 
transfectants exhibiting either high  (#27)  or low (#95) 
levels of MDR protein overexpression (see Table I) and 
compared  this accumulation  to that exhibited by con- 
trol  kR73/neo  transfectants  pulse  elevated  in  pHi  by 
the CO 2 pulse method  or depolarized in high  [K  +] me- 
dium  as described above  (Fig.  11).  The  two- to  three- 
fold levels of drug resistance are essentially mirrored by 
about  twofold  lower  drug  accumulation  as  measured 
under  these conditions  (Fig. 11,  open and solid bars). In 
contrast,  relative  accumulation  of  3H  vinca  is  more 
markedly reduced  for clone #27  (to ~6%  of the  level 
seen in the controls), which is consistent with the com- 
paratively high level of vinca resistance for this cell line 
(~10-fold) shown in Table I. 
We emphasize that one should not expect a linear or 
simple  correspondence  between  fold  drug  accumula- 
tion and fold drug resistance. Even if cells accumulate 
very similar levels of a weakly basic drug, if that drug is 
compartmentalized  inside  the  cell in  a  different fash- 
ion  (due  to, for example, different ApH between cyto- 
solic and vacuolar milieu), the accessibility of the drug 
to  its  target  may be  different,  further  affecting  resis- 
tance. Nonetheless, a few general expectations are veri- 
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fled by these results, including that depolarization does 
not  appear  to  alter  accumulation  of  the  uncharged 
drug  colchicine  as  dramatically  as  it  does  the  other 
compounds,  although it does appear to have a  mild ef- 
fect (see also Wei et al., 1995). 
DISCUSSION 
Which Cellular Alterations Are Unequivocally  due to MDR 
Protein Overexpression ? 
Although many studies have  previously noted elevated 
pH i for MDR cells (reviewed in Roepe, 1995), there has 
been at least one contrasting observation for a  chemo- 
therapeutic  drug-selected  cell  line  (Altenberg  et  al., 
1993)  in a study that used different techniques, relative 
to  most other work. 5 Along with  elevated pHi,  several 
other  important  biophysical  characteristics  of  MDR 
cells  have  been  reported,  including  decreased  Vm 
(Roepe et al., 1993),  altered C1- transport  (Valverde et 
al., 1992),  altered membrane  lipid composition  (Ramu 
et al.,  1984),  and  increased vesicular traffic  (Sehested 
et  al.,  1987).  It is  not  difficult to  envision  how  these 
characteristics might contribute  to drug  resistance via 
~Altenberg  et al.  (1993) analyzed  pH  i for populations of 100-150 
cells in an atmosphere of 95% ()~ after loading the cells with BCECF- 
AM for relatively long time  (60 rain) in the presence of detergent 
(the pluronic F-127), techniques which are not followed in other work 
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FIGURE 11.  Relative percent accumulation  of :4H analogues  of 
representative  chemotherapeutics (daunorubicin  [open ba~], vin- 
blastine [dotted bars] and colchicine [solid bars], see MATEmALS  AND 
METHODS) for (from left to right) control LR73/neo transfectants 
without  MDR protein expression,  clone #27, clone #95, control 
transfectants pulse elevated in pH  i by 0.21 U as described in Fig. 8, 
and  control  transfectants  depolarized  25  mV by incubation  in 
DME medium containing  127 mM K  + (see MATERIALS  AND METH- 
ODS) as described  in Fig. 10. Daunorubicin  and vinblastine were 
available as less expensive "~H analogues  (New England  Nuclear 
and  Amersham,  respectively).  Differences  in  cell  resistance  to 
daunorubicin vs. doxorubicin  (which differ by a single OH group) 
or to vincristine vs. vinblastine (which differ by a single oxygen on 
the catharanthine group) are not statistically different for the cell 
lines described  (Wei, L.Y., and Roepe, P.D., unpublished  data, and 
see RESULTS).  The most profound alteration in accumulation is for 
clone #27, which accumulates about 6% of vinca alkaloid, relative 
to controls. 
altering diffusion or partitioning of hydrophobic drugs 
(Roepe, 1995), thus it is tempting to conclude that they 
may be directly or indirectly due to MDR protein over- 
expression. However, as is the case with elevated phi, a 
few contrasting observations with respect to these phe- 
notypic features have also been reported  (e.g., Ehring 
et al.,  1994;  Callaghan  et al.,  1992).  Therefore,  it has 
been argued that these features might be epiphenom- 
ena unrelated to MDR protein overexpression. 
In analyzing experiments with MDR cells, it must be 
emphasized that chemotherapeutic drugs are very pow- 
erful compounds. They are not only toxic, but most are 
mutagenic  or  even  teratogenic,  and  in  certain  situa- 
tions  they  induce  differentiation  and  other  complex 
phenomena.  For example, anthracyclines  like doxoru- 
bicin form reactive semiquinones  and aglycones upon 
one and two electron  reduction,  form complexes with 
iron  and  other ions,  significantly perturb  the  physical 
characteristics of membranes, and may even alter criti- 
cal signal transduction.  They alkylate DNA, poison mi- 
tochondria, inhibit topoisomerases and other enzymes, 
and directly modulate second messenger levels, among 
having other effects. As analysis of MDR protein func- 
tion  has  become  more  detailed,  it  has  therefore  be- 
come  increasingly  difficult  to  separate  effects  due  to 
MDR protein overexpression from other effects due to 
drug exposure,  and  this  has dramatically confused  in- 
terpretation.  Although  heterologous  expression  of 
MDR proteins (e.g., in yeast or bacteria) offers one ave- 
nue  for improvement,  these  systems obviously do  not 
accurately model tumor cells,  thus important pharma- 
cologic issues cannot be explored. Also,  in  contrast to 
some  current  practices,  data  collected  with  heterolo- 
gous systems need to be interpreted based on expecta- 
tions  that  come from the  study of pure  transfectants, 
not drug selected MDR cells. 
Construction of "True" MDR Transfectants 
Therefore, it is crucial  that phenotypic alterations  un- 
equivocally due to MDR protein overexpression be pre- 
cisely defined. As described, one convenient way to do 
this is to study pure MDR 1 transfectants that are not se- 
lected or maintained  on chemotherapeutic  drugs.  We 
have  successfully  engineered  a  series  of  these  pure 
transfectants exhibiting different levels of MDR protein 
overexpression.  Surprisingly,  the  level  of  drug  resis- 
tance exhibited by the clones is much lower than might 
be  expected  based  on  the  behavior  of drug-selected 
MDR cells. Our data show that exposure to chemother- 
apeutic  drugs  is  more  important  for conferring  high 
(>10-fold)  levels of resistance  than  the  MDR protein 
overexpression  that  might  accompany  this  exposure. 
This  point is important when  considering  how exten- 
sively MDR protein might alter cellular drug accumula- 
tion. That is,  a common misconception based on high 
levels of resistance for drug selected MDR cells is that 
MDR protein  overexpression must somehow lower in- 
tracellular levels of drugs by a much larger extent than 
is  the  case  (Fig.  11).  Reduced  accumulation  due  to 
MDR protein  can  be  easily explained  by Vm  and  pH~ 
perturbations  (Wadkins  and  Roepe,  1996),  and  does 
not require that we invoke a drug pump model (Gottes- 
man and Pastan,  1993; Higgins and Gottesman, 1992). 
Many  laboratories  have  had  difficulty  constructing 
pure  transfectants  for reasons  that  remain vague,  but 
that might be a consequence of relatively poor chromo- 
somal  integration  of the  very large  MDR  1  cDNA,  or 
perhaps deleterious effects of the protein. The latter is 
suggested  due  to  the  loss  of MDR protein  expression 
for some clones passaged multiple  (one to two dozen) 
times. We could not unequivocally conclude if this was 
a  random  or  directed  genetic  event,  but  clonal  selec- 
tion and the frequency of this phenomenon  (Hoffman, 
M.M.,  and P.D.  Roepe,  unpublished  data)  suggest the 
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could also be due to the cDNA integration context for 
particular clones. The fact that clones #24 and #27  (as 
well as several other high-level expressors recently iso- 
lated,  data not shown)  exhibit a  stable  phenotype ar- 
gues against a strong selective advantage for low expres- 
sion under our culture conditions. In any case, since we 
have  isolated  several  independent  high-level  overex- 
pressing clones that exhibit a similar and stable pheno- 
type  (Table I)  at a  low but reasonable frequency (see 
MATERIALS AND METHODS), it is unlikely that we prefer- 
entially isolate clones expressing  randomly generated 
MDR 1 mutants. 
Characteristics of the Clones and Implications for Multidrug 
Resistance 
These clones exhibit:  (a)  elevated pHi and altered pHi 
regulation,  (b)  lowered V .... (c)  low levels of drug resis- 
tance that can be explained by the changes in pHi and/ 
or Vm,  and  (d)  partial  reversal  of drug  resistance  by 
nontoxic levels of verapamil and cyclosporin A. 6 
Trends  in  alkalinization  and  depolarization  are  ap- 
parent  upon  plotting  these  parameters  vs.  MDR  pro- 
tein  expression  (Fig.  12);  however,  analysis  of more 
clones is required before these  trends  should be con- 
sidered universal. When the sum  ofV m and ApH is plot- 
ted vs. relative MDR protein overexpression (Fig. 12 C), 
a nearly flat line is obtained, as also reported for drug 
selected myeloma derivatives (Roepe et al., 1993), indi- 
cating the decrease in Vm nearly mirrors the increase in 
ApH.  Importantly,  however, since  different cells have 
different mechanisms and priorities for regulating pHi, 
V .... and  volume, different degrees of the  changes  we 
have found are likely for different cell types (e.g., cells 
with high vs.  low Na+/H -  exchanger activity, or AE  1 
vs. AE 2 isoform expression) engineered to overexpress 
MDR protein. 
By comparing Table I to Figs. 8, 9, 10, and 11 and to 
data recently published elsewhere (Wei et al., 1995), we 
propose that changes in Vm and pH~ for the MDR trans- 
fectants are sufficient to confer the levels of drug resis- 
tance due to MDR protein overexpression. It is unnec- 
essary  to  invoke  a  nonspecific  drug  pump  model  to 
explain  the  MDR protein-mediated MDR phenotype. 
The pH~/Vm altered partitioning model avoids the sig- 
nificant  kinetic,  thermodynamic,  and  specificity diffi- 
culties inherent in the drug pump model (Roepe et al., 
6The molecular effects of reversal agents are complicated  (see Wad- 
kins and Houghton, 1993), and we will address several of these issues 
elsewhere  (Wei, L.Y.,  and P.D.  Roepe,  manuscript in preparation). 
Interestingly, however, Keizer andJoenje  (1989)  as well as our own 
laboratory  (Roepe,  1992)  previously reported  that exposure to vera- 
pamil Dowered elevated pH  i fi)r MDR cell lines, and the Gnpta labora- 
tory  (Vayuvegula et al.,  1988)  previously reported  that either  vera- 
pamil or cyclosporin A repolarized MDR cells. 
1996; Wadkins and Roepe, 1996). However, several im- 
portant questions remain. For example, we do not yet 
know whether pHi and Vm effects are additive or syner- 
gistic with respect to drug resistance. It is reasonable to 
suggest  that  changes  in  cytosolic  pHi  might  perturb 
subcellular  distribution  of  some  weakly  basic  drugs 
since  the  ApH across compartmental  membranes will 
also be altered. This effect and others likely have addi- 
tional  impact  upon  drug  partitioning  and  resistance 
(see Roepe, 1995; Wadkins and Roepe, 1996). The sole 
explanation for drug resistance due to changes in pH~ 
and  Vm  is  likely  not  simplified  altered  equilibrium 
transmembraneous  distribution  (e.g., weak base parti- 
tioning or altered  equilibrium  partitioning  of cations 
due to altered Vm). In contrast, MDR is likely due to the 
sum of several mechanisms acting together. Due to the 
complexity of chemotherapeutic drug action, which in- 
cludes cytotoxic and growth inhibitory functions as well 
as the ability to induce programmed cell death, or apop- 
tosis  (interestingly, an apparently pHi-dependent pro- 
cess, see Li and Eastman,  1995; Pdrez-Sala et al., 1995), 
we  do  not necessarily expect simple  relationships  be- 
tween drug transport and drug resistance. 
Exposure of our cell lines  to different chemothera- 
peutic drugs alters the level of drug resistance and the 
resistance profile. These results have important impli- 
cations  for studies  wherein  mutant  MDR  cDNAs  are 
transfected into cells that are then subsequently grown 
in the presence of drugs under different conditions rel- 
ative to cells transfected with wild-type cDNA (see Choi 
et al.,  1988; Gros et al.,  1991). These data have almost 
always been interpreted to mean that the mutant MDR 
proteins must pump various  drugs with  different effi- 
ciencies,  relative  to  the  wild  type,  because  the  drug 
binding site has  been mutated. Alternatively, perhaps 
the data indicate other (non-MDR protein-mediated) 
drug  resistance  mechanisms  have  been  induced with 
different efficiencies upon the different drug-selection 
conditions. 
Possible Complexities in Interpretation of the Present Data 
Since much of our analysis depends upon intracellular 
probes and since the MDR phenotype is characterized 
by altered cellular retention of compounds, we are con- 
cerned  about  possible  complexities in  interpretation. 
Some investigators propose that fluorometric probes of 
pH~ and Vm are pumped by the MDR protein and that 
this pumping function could alter our conclusions. Sev- 
eral  arguments  suggest  this  is  not  the  case:  (a)  Our 
measurements of loading and leak of BCECF-AM and 
BCECF,  respectively, are  in  contrast to previous work 
with  drug selected  cells  (Homolya et al.,  1993).  Our 
data  argue  that  AM  derivatives  are  not  pumped  by 
MDR protein and that previous observations that led to 
this conclusion may be due to drug selection or other 
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FmURE  12.  Relationship  be- 
tween  relative  MDR  protein  ex- 
pression in the series of transt~c- 
tants and  (A) pHi, (B) V,,, (from 
Table I), and (C) the mathemati- 
cal sum of  pH and V,,, (in mV, 
tbllowing the convention  that al- 
kaline  inside  is  negative).  In  A 
and B the data are fit by a 2nd or- 
der polynomial, R'-'  > 0.82 in each 
case. 
factors. Even if the compound was somehow pumped, 
the fact that the different standard  curves have similar 
slope  (see Fig. 3) shows our calibration in different cell 
lines is reliable. Via similar arguments, ratiometric mea- 
surements with ANEPPS are reliable.  (b)  Previous anal- 
ysis  of the  rate  of carbocyanine  effiux from  MDR vs. 
sensitive cells showed that there was essentially no dif- 
ference  (Roepe et al.,  1993);  if these compounds were 
pumped out of the  cell by MDR protein  there  should 
be an increased rate of effiux (see Roepe, 1992).  (c) Dif- 
ferent members of the diOC,(3)  series are very similar 
in chemical structure;  much more similar than, for ex- 
ample, vincristine and doxorubicin which, via the pump 
hypothesis, are both substrates for the pump. Although 
we cannot completely disprove the notion, it is thus diffi- 
cult to envision why the putative pump would recognize 
vincristine, doxorubicin, and diOC5 (3), but not diOC7(3 ). 
A  simpler explanation,  also consistent with  other data 
(see Roepe et al.,  1993;  Luz et al.,  1994;  Roepe,  1995; 
Table I), is that the MDR clones have lower Vm- 
Future Implications 
These  data  strongly  support  the  altered  partitioning 
model for MDR protein  function  (Roepe,  1995;  Wad- 
kins and Roepe,  1996),  resolve several unsettled  phar- 
macologic issues  in  the  MDR literature,  and  have im- 
portant  implications  for  the  continued  evolution  of 
chemotherapy. Consideration of physical-chemical fac- 
tors in describing the pharmacology of drugs is almost 
as old as pharmacology itself; however, appreciation for 
the extent and manner in which cells and microorgan- 
isms can alter physical-chemical effects in the course of 
developing drug resistance is less well appreciated. Ex- 
amination  of the  literature  pertaining  to other  exam- 
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ples of"ABC-MDR" (i.e., overexpression or mutation of 
a member of the ABC family thereby conferring pleio- 
tropic  drug  resistance),  for  example,  pfMDRl-medi- 
ated  chloroquine  resistance  in  malarial  parasites  per- 
haps being accompanied by altered ApH for digestive 
vacuoles,  multidrug  resistance-related  protein-medi- 
ated drug resistance in lung carcinoma perhaps being 
accompanied by alterations in CI- and K + transport, or 
the  apparent  role  of V,,, in  the  CFTR-mediated  MDR 
phenotype  (Wei  et al.,  1995),  leads  us  to suggest  two 
important  possibilities:  (a)  a  general  mechanism  for 
how ABC transporters mediate drug resistance may ex- 
ist through the proteins regulating Vm, pHi, or volume, 
and (b)  other undiscovered pathways to drug resistance 
may also involve Vm/pH~ perturbations,  but via differ- 
ent molecular mechanisms.  Indeed, it is interesting to 
note that the B. subtilis tet B(L) locus (which confers tet- 
racycline  resistance)  encodes  a  Na+/H +  antiporter 
(Cheng et al.,  1994)  and that the sapABCDF complex, 
which  confers  resistance  to  toxic  peptides  and  other 
compounds in S.  typhimurium,  regulates K + channel ac- 
tivity (Parra-Lopez et al., 1994) 
We suggest that a variety of phenomena reported on 
in the MDR literature should be re-examined with cell 
lines similar to those used in the present work to deter- 
mine whether they are unequivocally due to MDR pro- 
tein overexpression. This point of view is reinforced by 
considering  the  levels of drug  resistance  exhibited  by 
pure MDR transfectants vs. selectants and drug-selected 
cells; in most reports it is not emphasized that these dif- 
fer greatly. Also, even if MDR protein overexpression is 
an important event in the development of a MDR phe- 
notype, other events that occur during continued drug 
selection  likely complicate matters.  These  might even 
be important targets for therapy. 
Tran.~bctants Based  on  this work and  other  analysis  (Roepe,  1995; 
Roepe  et al.,  1996; Wadkins  and  Roepe,  1996),  we feel 
the  altered  partioning  model  for  MDR  protein  is  cur- 
rently  much  more  reasonable,  even  if it  does  conflict 
with  the  very popular  drug  pump  model.  Its  valuable 
predictive abilities  (see also Wei and  Roepe,  1994; Wei 
et al.,  1995)  should  be examined  further. 
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